Shionogi Expands Cancer Vaccine License With Oncotherapy Science
This article was originally published in PharmAsia News
Executive Summary
Shionogi & Co. Ltd. signed a worldwide licensing agreement with Kawasaki-based OncoTherapy Science, March 29 to develop, manufacture and market cancer peptide vaccines.